Volume 7, Issue 4 (November 2020)                   Avicenna J Neuro Psycho Physiology 2020, 7(4): 231-235 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ziayee Chamgordani B, Bahreini Z, Kahrazee F. Effectiveness of Cognitive-Behavioral Therapy on Distress Tolerance and Coping with the Child’s Illness in Parents of Children with Thalassemia Major. Avicenna J Neuro Psycho Physiology 2020; 7 (4) :231-235
URL: http://ajnpp.umsha.ac.ir/article-1-212-en.html
1- MSc, Department of Psychology, Faculty of Psychology and Educational Science, University of Sistan and Baluchestan, Zahedan, Iran
2- Ph.D. Candidate, Department of Psychology, Zahedan Branch, Islamic Azad University, Zahedan, Iran
3- Associate Professor, Department of Psychology, Faculty of Psychology and Educational Sciences, University of Sistan and Baluchestan, Zahedan, Iran , Farhad_kahraz@ped.usb.ac.ir
Full-Text [PDF 1495 kb]   (458 Downloads)     |   Abstract (HTML)  (1570 Views)
Full-Text:   (698 Views)
Background
Thalassemia is one of the most common chronic heritable diseases worldwide, which can be observed in almost all races and causes many problems for the patient, family, and health system. Thalassemia major can be considered one of the biggest chronic physical disorders in Iran [1]. Regular visits to hospitals and clinics impair the normal trend of patients' life, limit their social life, and increase the mental stress and tension in the family [2]. Furthermore, parents confront mental distress when their children become ill. In most cases, the anxiety and distress of the parents are related to the severity of the disease and the therapeutic methods of the child [3].
Distress tolerance is one of the common topics for research in the field of the emotional disorder [4]. Moreover, it is a variable of individual differences, which refers to the capacity of experience and resistance to emotional disturbance [5]. Distress tolerance has increasingly been seen as an important factor in the growth of new insights on the onset and maintenance of mental health [6]. People with low endurance distress in a wrong attempt are engaged in behavioral disorders to deal with their negative emotions [7]. Furthermore, they attempt to relieve emotional pain by showing some malicious behaviors, such as drugs and alcohol consumption [8]. The emotions and physiological arousal caused by the stressful situation force the person to take strategies to deal with them, which is referred to as coping [9].
If individuals can better deal with their resources, they are less susceptible to vulnerable situations [10]. Studies in the field of health psychology have shown the positive effect of using compatible coping strategies, such as stress management based on cognitive-behavioral theory [11]. These treatments can play a role in coping, immunization, and prevention of the onset of various diseases and their complications by creating positive psychosocial factors [12]. With this background in mind, it is of utmost importance to improve the psychological status and positive psychological characteristics among the parents of children with thalassemia [13].
 
Objectives
This study aimed to answer the question of whether the recognition of behavioral therapy can affect distress tolerance and the level of coping with the child’s illness among the parents of children with thalassemia major.
 
Materials and Methods
This study was conducted based on a semi-experimental design with a pretest-posttest and a control group. The statistical population of the study included all parents of children with major thalassemia who referred to Ali Asghar Hospital, Zahedan, Iran, from November to February 2016. The sample size of 30 cases in each group was determined based on the effect size, alpha, and statistical power of 0.25, 0.05, 0.80, respectively. However, due to the absence of some participants, the number of participants in each test group was reduced to 20 cases in each group. 
The inclusion criteria were literacy and residency with a spouse in Zahedan, Iran, during the study. On the other hand, the parents who were absent in more than two sessions of training, and those who were exposed to severe stressors, such as the death of a family member and pregnancy during the research procedure, were excluded from the study. In total, 40 parents of children with major thalassemia who referred to the Thalassemia Department of Ali Asghar Hospital, Zahedan, Iran, were selected using the available sampling method and assigned into two groups of experimental (n=20) and control (n=20).
In order to collect information, the researchers introduced themselves to the clients and explained the research objectives and procedures. Following that, the parents were invited to participate in
the intervention sessions respecting the ethical considerations. Subsequently, those who met the inclusion criteria (parents of a child with major thalassemia and running the pretest) and were willing to participate in the research were enrolled in this study. Regarding the ethical considerations, the participants were informed of the voluntary nature of the study, and they were allowed to leave the study at any time and for any reason. Furthermore, they were assured of the confidentiality and anonymity of their data to observe privacy. It is worth mentioning that all the questionnaires were administered and analyzed by the researcher himself.
The subjects were randomly divided into experimental and control groups, and it was agreed that the intervention sessions would be held for the control group after the completion of the research. The experimental group participated in eight 90-min intervention sessions per week based on the cognitive psychotherapy in the hall of Hazrat Ali Asghar Hospital, Zahedan, Iran, on Wednesdays from 12 to 14:30.
The previous assignments were collected and discussed in each session, and a new weekly assignment was given to the parents. After completing eight training sessions, a posttest was administered to both groups. The sessions aimed to determine the effectiveness of the intervention based on behavioral-cognitive therapy in the improvement of distress tolerance, level of coping styles, as well as enhancement of coping with a child's illness. It is worth mentioning that it was tried to organize the sessions in the form of question and answer, as well as group discussions. Moreover, at the end of each session, assignments were assigned to the participants, and they were requested to complete them at home. At the beginning of the next session, the assignments were checked and the contents of the previous sessions were reviewed. It is of importance to mention that the intervention sessions based on cognitive-behavioral therapy lasted two months (Table 1).
 
Distress Tolerance Scale
This self-assessment index was developed by Simmons and Gather with 15 items and 4 sub-scales to measure the ability to withstand emotional distress [14]. The items are rated on a five-point Likert scale of 1=strongly agree, 2=slightly agree, 3=to the same extent agree and disagree, 4=slightly disagree, and 5=completely disagree. It should be noted that item 6 is scored reversely, and high scores indicate a high distress tolerance [14]. The criterion validity and good initial convergence of this tool have already been confirmed in previously conducted studies. The internal consistency of the total scale was estimated at 0.71; moreover, the
 
Table 1. Contents of the Treatment Sessions
Sessions Description
Session 1 Getting acquainted with members, as well as expressing the logic and aims of the training sessions for the parents of children with thalassemia
Session 2 Discussions on thalassemia and its impact on the caregiver's life
Session 3 Defining stress, as well as adaptive coping and relaxation training
Session 4 Problem-solving and problem design
Session 5 Identifying and rating moods, ways to recognize irrational thoughts.
Session 6 Teaching the re-evaluating of the thoughts and accompanying challenges
Session 7 Time Management training
Session 8 Anger management training and doing exercises to control anger
 
corresponding values for the tolerance, absorption, evaluation, and adjustment subscales were 0.54,0.54, 0.56, and 0.58, respectively [15]. In this study, Cronbach’s alpha coefficients for these scales were 0.72, 0.82, 0.78, and 0.70, respectively. In addition, the Cronbach’s alpha coefficient of the total scale was determined at 0.82.
 
Copping Health Inventory for Parents
This 45-item scale was developed by Hamilton et.al to measure the ability of a family to cope with an acute or chronic illness of one of the children. The internal consistency of the questionnaire has been estimated by two separate studies at 0.79 and 0.71 using Cronbach's alpha [16]. Based on the results obtained from several studies that utilized this scale, researchers have provided natural scores as a method for comparison [17]. Three proficient translators translated this tool into Persian using the translation back method, which is a suitable and acceptable technique for translating research tools into other languages. A pediatric nurse with an MA degree and a psychologist confirmed the face validity of the Persian version of this scale. Eventually, 10 mothers of children with chronic illness were requested to complete the checklist, and they were asked about the clarity of the phrases, followed by minor revisions based on their comments. The data were analyzed in SPSS software (version 22) through descriptive (mean±SD) and inferential (analysis of covariance) statistics.
 
Results
The mean (SD) ages of the experimental and control groups were 40.3 (6.1) and 41 (5.7) years (age range: 25 to 55), respectively. Table 2 tabulates the mean (SD) of the dependent variables in the experimental and control groups.
The results of multivariate covariance analysis with control of pretest scores showed that none of the controlled variables had a significant effect on posttest scores; however, the effects of the adjustment dimension were significant in this regard (Table 3).
Table 4 shows the results of multivariate covariance analysis by controlling the pretest scores. According to the results, distress (F=9.82, P<0.004), tolerance (F=5.12, P<0.030), absorbed (F=7.43, P<0.010), assessment (F=4.73, P<0.037), and adjustment dimensions (F=6.70, P<0.014) had a significant effect on the posttest scores and the group membership.
 
Table 2. Mean (SD) of the dependent variables in the experimental and control groups
Variables Experimental group Control group
Pretest Posttest Pretest Posttest
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Distress tolerance Tolerance 3.75 (1.1) 6.05 (2.32) 4.15 (1.26) 4.60 (1.35)
Attraction 4.20 (1.50) 6.40 (2.50) 3.80 (1.10) 4 (1.85)
Assessment 9.80 (3.73) 12.85 (4.33) 8.20 (1.60) 9.55 (1.46)
Regulation 5.30 (3.16) 6.90 (2.17) 4.05 (1.09) 5.35 (1.34)
Improvements in the level of coping with the disease First Factor 33.50 (5.90) 40.25 (7.91) 31 (3.30) 30.60 (2.68)
Second Factor 29.05 (7.25) 34.05 (7.08) 28.40 (2.68) 28.05 (2.89)
Third Factor 17.25 (2.67) 18.80 (2.84) 16.30 (2.20) 16 (1.79)
 

Table 3.
Multivariate covariance results of the experimental and control groups at the posttest
Source Special amount F df Error df hypothesis P Eta Statistical power
Special amount .69 3.26 4 30 .025 .303 .768
Distress (pretest) .933 .54 4 60 .709 .067 .161
Tolerance (pretest) .965 .28 4 30 .891 .034 .102
Absorption (pretest) .791 1.98 4 30 .123 .209 .525
Evaluation (pretest) .906 .78 4 30 .550 .094 .219
Adjustment (pretest) .645 4.12 4 30 .009 .355 .868
Group .808 1.78 4 30 .159 .192 .477
 

Table 4. Results of multivariate covariance of cognitive-behavioral therapy on the improvement of distress tolerance at the posttest
Source Dependent variables SS df MS F P Eta Statistical power
Group Distress Dimension 396.939 1 396.939 9.824 .004 .229 .86
Tolerance Dimension 18.283 1 18.283 5.12 .030 .134 .59
Absorbed Dimension 32.592 1 32.592 7.434 .010 .184 .75
Assessment Dimension 36.757 1 36.757 4.732 .037 .125 .52
Adjustment Dimension 15.022 1 15.022 6.706 .014 .169 .71
 
Table 5. Results of multivariate analysis of covariance for coping with the disease at the posttest
Source Special amount F df of Error Df hypothesis P Eta Statistical power
Special amount .485 8.24 4 31 .001 .51 .99
Coping disease (pretest) .797 1.98 4 31 .122 .203 .52
First factor (pretest) .822 1.68 4 31 .179 .178 .45
Second factor (pretest) .580 5.61 4 31 .002 .420 .95
Third factor (pretest) .554 6.24 4 31 .001 .446 .97
Group .290 18.97 4 31 .0001 .710 1.00
 
Table 6. Results of multivariate covariance of cognitive-behavioral therapy on the improvement of distress tolerance at the posttest
Source Dependent variables SS df MS F P Eta Statistical power
Group Coping with the Disease 1141.346 1 1141.346 32.61 .0001 .49 1.00
First Factor 189.279 1 189.279 5.53 .025 .14 .62
Second Factor 68.88 1 68.88 3.15 .085 .085 .40
Third Factor 3.280 1 3.280 1.91 .176 .053 .269
 
      

Figure 1.
Difference between pretest and posttest in terms of variables in the experimental group
 
Table 5 summarizes the results of multivariate covariance analysis by controlling the pretest scores of coping with the disease and its dimensions. The controlled variables (coping with the disease and the first factor) had no significant effect on the posttest scores; however, the effects of the third factor (Squat ETA of 0.446 and power test of 0.974) and the group membership (ETA of 0.710 and test power of 1.00) was significant showing very good adequacy of the sample size.
Table 6 indicates the significant effect of cognitive-behavioral therapy on the improvement of coping with the disease dimension (F=32.61, P<0.0001) and first factor (F=5.53, P<0.025); moreover, the cognitive-behavioral therapy shows a significant effect on the posttest scores and group membership.
Discussion
Thalassemia major is one of the diseases that require continuous care of parents, regular blood transfusions, and iron transplantation to survive. The results of this study showed an increase in the mean score of the distress tolerance in the experimental group after the intervention, compared to the control group. Kolivand et al. [15] showed the effect of the cognitive-behavioral intervention on distress reduction among patients with chronic pain. The results of a study conducted by Yazdanimehr et al. [16], Hadjistavropoulos et al. [17], and Fitzpatrick et al. [18] showed the effectiveness of cognitive-behavioral therapy in increasing the adaptability of the parents of children with chronic diseases. Cognitive-behavioral therapy holds that extreme thinking and data analysis distortion usually exacerbates depression and anxiety [18].
Li et al. reported the effectiveness of cognitive-behavioral therapy in alleviating anxiety among patients with coronary heart disease [19]. Similarly, Daniels reported the positive effects of this method on the outcomes of chronic conditions, such as thalassemia [20]. According to a study conducted by Kazantzis et al., cognitive-behavioral therapy had no significant effect on anxiety among patients with mood disorders [21]. However, the depression scores were significantly decreased in both groups, which was more significant in the experimental group (4.77 vs. 0.76). This method of therapy changes the way of thinking and benefits from the principles of conditional reinforcement [22]. During this treatment, a person with major thalassemia learns using cognitive techniques that s/he should try to achieve a better position. This continuously improves the patient's follow-up treatment condition, and at the same time, calmness and awareness [23].
Previous studies also reported the positive effects of cognitive-behavioral therapy on depression among different populations [24]. Jeyanantham et al. reported that cognitive-behavioral therapy had no significant effect on depression among patients with chronic coronary heart disease [25]. Despite a more significant decrease in the mean score of depression in the experimental group, between-group differences were not statistically significant at the posttest stage. An explanation for such insignificant between-group differences may be the relatively short course of the study.
In explaining these findings, it can be said that this treatment helps people understand that negative emotions may occur but they are not a permanent part of the person. This perspective strengthens ones' life expectancy and allows the individuals to focus on solving problems rather than responding to events involuntarily and recklessly, thereby bringing meaning to ones' life. In this study, interventions based on cognitive-behavioral therapy lead the patients to more adaptation and acceptance of treatment by correcting their misconceptions about medical treatment or complications of the disease. If individuals with chronic diseases have a positive opinion of themselves, they will have a better feeling about their disease. On the other hand, if there is a sense of uncertainty about the new identity, the methodology group behavior can be effective in the treatment of depression. Furthermore, group discussion is an effective factor in the improvement of the mental images of adolescents with thalassemia.
Regarding the limitations of this study, one can name the differences among participants concerning their reactions to depression, anxiety, and treatments. Moreover, states such as fatigue, anxiety, and sleeplessness might have affected the participants’ responses to the items. Therefore, it is recommended that further studies investigate the effects of cognitive-behavioral therapy on the other patient outcomes, such as quality of life, adherence to treatment, anger, coping, and adjustment. The results should be interpreted with caution due to the small number of participants and administration in one center. Accordingly, it is recommended that this study be replicated with a larger sample size using a multi-center design.
 
Conclusions
The results showed that cognitive-behavioral therapy increased the level of distress tolerance and improved the level of coping with the child's disease in the experimental group, compared to the control group. Evidence suggests that the parents of children with major thalassemia face many problems that can be lead to high levels of anxiety and depression, tolerance of distress at a low level, despair and disappointment, as well as guilty feelings.
 
Compliance with ethical guidelines
Regarding the ethical considerations, the participants were informed about the research objectives and procedures. Moreover, informed consent was obtained from them. They were also assured about the confidentiality of their information, and they were allowed to leave the study whenever they wish, and if desired, the results of the research would be available to them. 
The study protocol was approved by the Ethics Committee of Hormozgan University of Medical Sciences, Bandar Abbas, Iran (IR.HUMS.REC.1397.339).
 
Funding/Support
This study received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
 
Conflicts of Interest
The authors declare that they have no conflict of interest regarding the publication of the study.
 
References
  1. Bakhshi R, Bahreini M, Mirzaei K, Kiani J. The effect of group counseling on the quality of life in patients with major thalassemia referred to the thalassemia treatment center in Bushehr. Pajouhan Scientific Journal. 2018; 16(3):11-9. [DOI:10.21859/psj.16.3.11]
  2. Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression: a network
    meta-analysis. JAMA Psychiatry. 2019; 76(7):700-7. [DOI:10.1001/jamapsychiatry.2019.0268] [PMID] [PMCID]
  3. Wong MC, Sun J, Lee A, Stewart D, Cheng FF, Kan W, et al. The impact of a newly designed resilience-enhancing programme on parent-and teacher-perceived resilience environment among Health Promoting Schools in Hong Kong. Journal of Epidemiology & Community Health. 2009; 63(3):209-14. [DOI:10.1136/jech.2008.074260]
  4. Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. American Journal of Psychiatry. 1995; 152(3):352-7. [DOI:10.1176/ajp.152.3.352] [PMID]
  5. O'Cleirigh C, Ironson G, Smits JA. Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management
    of HIV? Behavior Therapy. 2007; 38(3):314-23. [DOI:10.1016/j.beth.2006.11.001] [PMID] [PMCID]
  6. Vlaeyen JW, Crombez G, Goubert L. The psychology of chronic pain and its management. Physical Therapy Reviews. 2007; 12(3):179-88. [DOI:10.1179/108331907X223001]
  7. Keough ME, Riccardi CJ, Timpano KR, Mitchell MA, Schmidt NB. Anxiety symptomatology: the association with distress tolerance and anxiety sensitivity. Behavior Therapy. 2010; 41(4):567-74. [DOI:10.1016/j.beth.2010.04.002] [PMID] [PMCID]
  8. Geschwind N, Arntz A, Bannink F, Peeters F. Positive cognitive behavior therapy in the treatment of depression: a randomized order within-subject comparison with traditional cognitive behavior therapy. Behaviour Research and Therapy. 2019; 116:119-30. [DOI:10.1016/j.brat.2019.03.005] [PMID]
  9. Aspinwall LG, Staudinger UM. A psychology of human strengths: fundamental questions and future directions for a positive psychology. Washington, DC: American Psychological Association; 2003. [DOI:10.1037/10566-000]
  10. Abel A, Hayes AM, Henley W, Kuyken W. Sudden gains in cognitive-behavior therapy for treatment-resistant depression: processes of change. Journal of Consulting and Clinical Psychology. 2016; 84(8):726-37. [DOI:10.1037/ccp0000101] [PMID]
  11. Bruijniks SJ, DeRubeis RJ, Hollon SD, Huibers MJ. The potential role of learning capacity in cognitive behavior therapy for depression: a systematic review of the evidence and future directions for improving therapeutic learning. Clinical Psychological Science. 2019; 7(4):668-92. [DOI:10.1177/2167702619830391]
  12. Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. American Psychologist. 2014; 69(2):153-66. [DOI:10.1037/a0035747] [PMID]
  13. Hastings RP, Kovshoff H, Ward NJ, Degli Espinosa F, Brown T, Remington B. Systems analysis of stress and positive perceptions in mothers and fathers of pre-school children with autism. Journal of Autism and Developmental Disorders. 2005; 35(5):635-44. [DOI:10.1007/s10803-005-0007-8] [PMID]
  14. Simons JS, Gaher RM. The distress tolerance scale: development and validation of a self-report measure. Motivation and Emotion. 2005; 29(2):83-102. [DOI:10.1007/
    s11031-005-7955-3]
  15. Kolivand P, Nazari Mahin A, Jafari R. The effectiveness of cognitive behavioral therapy on decrease of the distress in patients with chronic pain. The Neuroscience Journal
    of Shefaye Khatam. 2015; 3(3):63-9. [DOI:10.18869/
    acadpub.shefa.3.3.63]
  16. Yazdanimehr R, Omidi A, Sadat Z, Akbari H. The effect of mindfulness-integrated cognitive behavior therapy on depression and anxiety among pregnant women: a randomized clinical trial. Journal of Caring Sciences. 2016; 5(3):195-204. [DOI:10.15171/jcs.2016.021] [PMID] [PMCID]
  17. Hadjistavropoulos HD, Pugh NE, Hesser H, Andersson G. Predicting response to therapist-assisted internet-delivered cognitive behavior therapy for depression or anxiety within an open dissemination trial. Behavior Therapy. 2016; 47(2):155-65. [DOI:10.1016/j.beth.2015.10.006] [PMID]
  18. Fitzpatrick KK, Darcy A, Vierhile M. Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): a randomized controlled trial. JMIR Mental Health. 2017; 4(2):e19. [DOI:10.2196/mental.7785] [PMID] [PMCID]
  19. Li C, Xu D, Hu M, Tan Y, Zhang P, Li G, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. Journal of Psychosomatic Research. 2017; 95:44-54. [DOI:10.1016/j.jpsychores.2017.02.006] [PMID]
  20. Sheena Daniels D. Cognitive behavioral therapy in patients with sickle cell disease. Creative Nursing. 2015; 21(1):38-46. [DOI:10.1891/1078-4535.21.1.38] [PMID]
  21. Kazantzis N, Clayton X, Cronin TJ, Farchione D, Limburg K, Dobson KS. The cognitive therapy scale and cognitive therapy scale-revised as measures of therapist competence in cognitive behavior therapy for depression: Relations with short and long term outcome. Cognitive Therapy and Research. 2018; 42(4):385-97. [DOI:10.1007/s10608-018-9919-4]
  22. Bahreinian SA, Davoodi SM. The comparison of behavioral and cognitive behavioral therapeutic methods on depression in cardiac rehabilitated patients. Pejouhesh dar Pezeshki. 2009; 32(4):289-96.
  23. Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Internal Medicine. 2015; 175(11):1773-82. [DOI:10.1001/
    jamainternmed.2015.5220]
    [PMID] [PMCID]
  24. Spinhoven P, Klein N, Kennis M, Cramer AO, Siegle G, Cuijpers P, et al. The effects of cognitive-behavior therapy for depression on repetitive negative thinking: a meta-analysis. Behaviour Research and Therapy. 2018; 106:71-85. [DOI:10.1016/j.brat.2018.04.002]
  25. Jeyanantham K, Kotecha D, Thanki D, Dekker R, Lane DA. Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis. Heart Failure Reviews. 2017; 22(6):731-41. [DOI:10.1007/s10741-017-9640-5] [PMID] [PMCID]

 
Article Type: Research Article | Subject: Mother and child health
Received: 2019/12/2 | Accepted: 2020/06/25 | Published: 2020/11/16

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY 4.0 | Avicenna Journal of Neuro Psycho Physiology

Designed & Developed by : Yektaweb